Kovack Advisors, Inc. Nektar Therapeutics Transaction History

Kovack Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$46.25 - $104.45 $146,427 - $330,688	-3,166 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $46,436 - $87,727	-809 Reduced 20.35%	3,166 $336,000
Q4 2017 May 15, 2018	SELL	$23.02 - $60.5 $1,197 - $3,146	-52 Reduced 1.29%	3,975 $237,000
Q4 2017 Feb 01, 2018	BUY	$23.02 - $60.5 $92,701 - $243,633	4,027	4,027 $240,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.